2024 Q3 Form 10-Q Financial Statement

#000165495424009573 Filed on July 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $6.153M $6.125M $3.237M
YoY Change 86.39% 89.26% 37.23%
Cost Of Revenue $3.156M $3.052M $2.443M
YoY Change 43.76% 24.93% 3.91%
Gross Profit $2.997M $3.073M $793.6K
YoY Change 171.03% 287.28% 10542.12%
Gross Profit Margin 48.71% 50.18% 24.52%
Selling, General & Admin $354.8K $302.6K
YoY Change 17.25% -34.72%
% of Gross Profit 11.54% 38.13%
Research & Development $620.1K $207.4K
YoY Change 199.01% -46.39%
% of Gross Profit 20.17% 26.13%
Depreciation & Amortization $455.9K $343.0K
YoY Change 32.91% 41.81%
% of Gross Profit 14.83% 43.23%
Operating Expenses $1.558M $977.8K $503.6K
YoY Change 124.97% 94.17% -41.04%
Operating Profit $1.440M $2.096M $290.0K
YoY Change 248.17% 622.65% -134.25%
Interest Expense $37.13K $25.60K $19.37K
YoY Change 234.28% 32.15% 144.81%
% of Operating Profit 2.58% 1.22% 6.68%
Other Income/Expense, Net -$550.0K -$39.33K $0.00
YoY Change -100.0%
Pretax Income $2.135M $295.8K
YoY Change 621.7% -134.71%
Income Tax
% Of Pretax Income
Net Earnings $1.990M $2.135M $295.8K
YoY Change 392.47% 621.69% -134.71%
Net Earnings / Revenue 32.33% 34.85% 9.14%
Basic Earnings Per Share
Diluted Earnings Per Share $0.17 $0.03
COMMON SHARES
Basic Shares Outstanding 12.96M shares 12.74M shares 12.26M shares
Diluted Shares Outstanding 13.26M shares 13.04M shares 12.26M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.146M $2.238M
YoY Change 263.95% -28.57%
Cash & Equivalents $8.393M $1.801M $2.230M
Short-Term Investments $6.345M $8.220K
Other Short-Term Assets $405.3K $172.0K $121.6K
YoY Change 21.53% 41.45% -78.35%
Inventory $971.5K $766.6K $655.3K
Prepaid Expenses
Receivables $1.517M $840.3K
Other Receivables $1.420K $1.550K
Total Short-Term Assets $14.44M $10.60M $3.857M
YoY Change 248.58% 174.89% -24.06%
LONG-TERM ASSETS
Property, Plant & Equipment $11.57M $10.49M $10.79M
YoY Change 9.58% -2.73% 26.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $8.220K
YoY Change -100.0% -98.11%
Other Assets $600.3K $0.00
YoY Change -100.0%
Total Long-Term Assets $26.39M $21.58M $18.92M
YoY Change 40.68% 14.05% 17.51%
TOTAL ASSETS
Total Short-Term Assets $14.44M $10.60M $3.857M
Total Long-Term Assets $26.39M $21.58M $18.92M
Total Assets $40.83M $32.19M $22.78M
YoY Change 78.29% 41.29% 7.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $732.8K $542.8K
YoY Change 35.0% -23.92%
Accrued Expenses $286.2K $235.5K
YoY Change 21.55% 8.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $745.1K $1.044M
YoY Change -28.59% 37.89%
Total Short-Term Liabilities $2.615M $1.764M $1.822M
YoY Change 48.62% -3.17% 7.93%
LONG-TERM LIABILITIES
Long-Term Debt $1.986M $1.739M
YoY Change 14.21% 57.18%
Other Long-Term Liabilities $295.9K $270.1K
YoY Change 9.55% 6.08%
Total Long-Term Liabilities $2.418M $2.282M $2.009M
YoY Change 35.44% 13.58% 25.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.615M $1.764M $1.822M
Total Long-Term Liabilities $2.418M $2.282M $2.009M
Total Liabilities $5.033M $4.046M $3.831M
YoY Change 41.98% 5.62% 16.3%
SHAREHOLDERS EQUITY
Retained Earnings $10.88M -$12.88M -$17.98M
YoY Change -161.95% -28.36% 5.1%
Common Stock $43.93M $38.26M $34.12M
YoY Change 28.73% 12.13% 6.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $33.05M $25.38M $16.14M
YoY Change
Total Liabilities & Shareholders Equity $40.83M $32.19M $22.78M
YoY Change 78.29% 41.29% 7.55%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income $1.990M $2.135M $295.8K
YoY Change 392.47% 621.69% -134.71%
Depreciation, Depletion And Amortization $455.9K $343.0K
YoY Change 32.91% 41.81%
Cash From Operating Activities $2.630M $982.6K
YoY Change 167.62% -216.09%
INVESTING ACTIVITIES
Capital Expenditures $880.1K $453.6K
YoY Change 94.02% -218.63%
Acquisitions
YoY Change
Other Investing Activities -$6.328M $0.00
YoY Change -100.0%
Cash From Investing Activities -$7.208M -$453.6K
YoY Change 1488.99% -24.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.084M -312.8K
YoY Change -446.67% -126.71%
NET CHANGE
Cash From Operating Activities 2.630M 982.6K
Cash From Investing Activities -7.208M -453.6K
Cash From Financing Activities 1.084M -312.8K
Net Change In Cash -3.494M 216.2K
YoY Change -1716.03% -178.47%
FREE CASH FLOW
Cash From Operating Activities $2.630M $982.6K
Capital Expenditures $880.1K $453.6K
Free Cash Flow $1.749M $529.0K
YoY Change 230.73% -214.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Cost Direct Material
CostDirectMaterial
2099890 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
455930 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
957718 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001030192
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2024Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12958574 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12397615 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41320
dei Entity Registrant Name
EntityRegistrantName
IDAHO STRATEGIC RESOURCES, INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
ID
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-0490295
dei Entity Address Address Line1
EntityAddressAddressLine1
201 N. Third Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Coeur d’Alene
dei Entity Address State Or Province
EntityAddressStateOrProvince
ID
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
83814
dei City Area Code
CityAreaCode
208
dei Local Phone Number
LocalPhoneNumber
625-9001
dei Security12b Title
Security12bTitle
Common Stock, $0.00 par value
dei Trading Symbol
TradingSymbol
IDR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12958574 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1801257 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2286999 usd
CY2024Q2 us-gaap Other Short Term Investments
OtherShortTermInvestments
6344725 usd
CY2023Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
0 usd
CY2024Q2 us-gaap Other Receivables
OtherReceivables
1516514 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
1038867 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
766612 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
876681 usd
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1413 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2080 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
5649 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
172036 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
236837 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
10602557 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4447113 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10492298 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10233640 usd
CY2024Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
9459771 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
7898878 usd
CY2024Q2 njmc Investment Non Cuurent
InvestmentNonCuurent
339047 usd
CY2023Q4 njmc Investment Non Cuurent
InvestmentNonCuurent
338769 usd
CY2024Q2 njmc Investment In Long Term Entity
InvestmentInLongTermEntity
435000 usd
CY2023Q4 njmc Investment In Long Term Entity
InvestmentInLongTermEntity
435000 usd
CY2024Q2 njmc Reclamation Bonds
ReclamationBonds
256310 usd
CY2023Q4 njmc Reclamation Bonds
ReclamationBonds
251310 usd
CY2024Q2 us-gaap Deposit Assets
DepositAssets
600267 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
285079 usd
CY2024Q2 us-gaap Assets
Assets
32185250 usd
CY2023Q4 us-gaap Assets
Assets
23889789 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
732832 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
484221 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
286187 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
266670 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
745132 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
978246 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1764151 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1729137 usd
CY2024Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
295874 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
286648 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1985742 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1338406 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2281616 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1625054 usd
CY2024Q2 us-gaap Liabilities
Liabilities
4045767 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3354191 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12958574 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12397615 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
38264643 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
34963739 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12881656 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17210638 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
25382987 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
17753101 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
2756496 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
2782497 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28139483 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20535598 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32185250 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23889789 usd
CY2024Q2 njmc Sales Of Products
SalesOfProducts
6125382 usd
njmc Sales Of Products
SalesOfProducts
12024320 usd
CY2023Q2 njmc Sales Of Products
SalesOfProducts
3236515 usd
njmc Sales Of Products
SalesOfProducts
6578111 usd
CY2024Q2 us-gaap Revenues
Revenues
6125382 usd
us-gaap Revenues
Revenues
12024320 usd
CY2023Q2 us-gaap Revenues
Revenues
3236515 usd
us-gaap Revenues
Revenues
6578111 usd
CY2024Q2 us-gaap Cost Direct Material
CostDirectMaterial
2596027 usd
us-gaap Cost Direct Material
CostDirectMaterial
5154940 usd
us-gaap Cost Direct Material
CostDirectMaterial
4247850 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
343042 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
671079 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
3051957 usd
us-gaap Cost Of Revenue
CostOfRevenue
6112658 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
2442932 usd
us-gaap Cost Of Revenue
CostOfRevenue
4918929 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
3073425 usd
us-gaap Gross Profit
GrossProfit
5911662 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
793583 usd
us-gaap Gross Profit
GrossProfit
1659182 usd
CY2024Q2 us-gaap Exploration Expense
ExplorationExpense
620056 usd
us-gaap Exploration Expense
ExplorationExpense
887904 usd
CY2023Q2 us-gaap Exploration Expense
ExplorationExpense
207369 usd
us-gaap Exploration Expense
ExplorationExpense
480811 usd
CY2024Q2 us-gaap Management Fee Expense
ManagementFeeExpense
90313 usd
us-gaap Management Fee Expense
ManagementFeeExpense
199413 usd
CY2023Q2 us-gaap Management Fee Expense
ManagementFeeExpense
55568 usd
us-gaap Management Fee Expense
ManagementFeeExpense
124479 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
84982 usd
us-gaap Professional Fees
ProfessionalFees
239226 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
123238 usd
us-gaap Professional Fees
ProfessionalFees
364043 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
179456 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
340119 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
123765 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
387063 usd
CY2024Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3022 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7431 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
6344 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
224 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
977829 usd
us-gaap Operating Expenses
OperatingExpenses
1674093 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
503596 usd
us-gaap Operating Expenses
OperatingExpenses
1356172 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2095596 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4237569 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
289987 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
303010 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1589 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-278 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1007 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1357 usd
CY2024Q2 njmc Timber Revenue Net Of Costs
TimberRevenueNetOfCosts
-6049 usd
njmc Timber Revenue Net Of Costs
TimberRevenueNetOfCosts
-19406 usd
CY2023Q2 njmc Timber Revenue Net Of Costs
TimberRevenueNetOfCosts
0 usd
njmc Timber Revenue Net Of Costs
TimberRevenueNetOfCosts
-20724 usd
CY2024Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
0 usd
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
453 usd
CY2023Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
2880 usd
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
2880 usd
CY2024Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-21862 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-21862 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2024Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
38606 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
58241 usd
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
18756 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
37693 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
25602 usd
us-gaap Interest Expense
InterestExpense
46167 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
11048 usd
us-gaap Interest Expense
InterestExpense
19896 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-39326 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-53167 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5835 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-36998 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
2134922 usd
us-gaap Net Income Loss
NetIncomeLoss
4290736 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
295822 usd
us-gaap Net Income Loss
NetIncomeLoss
340008 usd
CY2024Q2 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
-22951 usd
us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
-38246 usd
CY2023Q2 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
-31971 usd
us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
-48384 usd
CY2024Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
2157873 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
4328982 usd
CY2023Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
327793 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
388392 usd
CY2024Q2 njmc Earning Per Common Share Basic
EarningPerCommonShareBasic
0.17
njmc Earning Per Common Share Basic
EarningPerCommonShareBasic
0.34
CY2023Q2 njmc Earning Per Common Share Basic
EarningPerCommonShareBasic
0.03
njmc Earning Per Common Share Basic
EarningPerCommonShareBasic
0.03
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12836205 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12674789 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12256523 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12228844 shares
CY2024Q2 njmc Net Income Per Common Share Diluted
NetIncomePerCommonShareDiluted
0.17
njmc Net Income Per Common Share Diluted
NetIncomePerCommonShareDiluted
0.34
CY2023Q2 njmc Net Income Per Common Share Diluted
NetIncomePerCommonShareDiluted
0.03
njmc Net Income Per Common Share Diluted
NetIncomePerCommonShareDiluted
0.03
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13043026 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12904998 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12259438 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12232638 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
17713070 usd
CY2023Q1 njmc Contribution From Non Controlling Interest In New Jersey Mill Joint Venture
ContributionFromNonControllingInterestInNewJerseyMillJointVenture
1601 usd
CY2023Q1 njmc Issuance Of Common Stock For Cash Net Of Offering Costs Amount
IssuanceOfCommonStockForCashNetOfOfferingCostsAmount
878503 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
44186 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
18637360 usd
CY2023Q2 njmc Contribution From Non Controlling Interest In New Jersey Mill Joint Venture
ContributionFromNonControllingInterestInNewJerseyMillJointVenture
16409 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
295822 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
18949591 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20535598 usd
CY2024Q1 njmc Contribution From Non Controlling Interest In New Jersey Mill Joint Venture
ContributionFromNonControllingInterestInNewJerseyMillJointVenture
1598 usd
CY2024Q1 njmc Issuance Of Common Stock For Cash Net Of Offering Costs Amount
IssuanceOfCommonStockForCashNetOfOfferingCostsAmount
847492 usd
CY2024Q1 njmc Issuance Of Common Stock For Warrants Exercised Amount
IssuanceOfCommonStockForWarrantsExercisedAmount
823346 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
29999 usd
CY2024Q1 njmc Issuance Of Common Stock For Cashless Option Exercise Amount
IssuanceOfCommonStockForCashlessOptionExerciseAmount
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
2155814 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24393847 usd
CY2024Q2 njmc Contribution From Non Controlling Interest In New Jersey Mill Joint Venture
ContributionFromNonControllingInterestInNewJerseyMillJointVenture
10647 usd
CY2024Q2 njmc Issuance Of Common Stock For Cash Net Of Offering Costs Amount
IssuanceOfCommonStockForCashNetOfOfferingCostsAmount
1313392 usd
CY2024Q2 njmc Issuance Of Common Stock For Warrants Exercised Amount
IssuanceOfCommonStockForWarrantsExercisedAmount
166673 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
120002 usd
CY2024Q2 njmc Issuance Of Common Stock For Cashless Option Exercise Amount
IssuanceOfCommonStockForCashlessOptionExerciseAmount
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
2134922 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28139483 usd
us-gaap Profit Loss
ProfitLoss
-4290736 usd
us-gaap Profit Loss
ProfitLoss
-340008 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
957718 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
671079 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7431 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
224 usd
njmc Accretion Of Asset Retirement Obligation
AccretionOfAssetRetirementObligation
-9226 usd
njmc Accretion Of Asset Retirement Obligation
AccretionOfAssetRetirementObligation
-7856 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-453 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2880 usd
us-gaap Interest Income Short Term Investment Increase Decrease
InterestIncomeShortTermInvestmentIncreaseDecrease
21862 usd
us-gaap Interest Income Short Term Investment Increase Decrease
InterestIncomeShortTermInvestmentIncreaseDecrease
0 usd
njmc Income Loss From Equity Method Investment
IncomeLossFromEquityMethodInvestment
278 usd
njmc Income Loss From Equity Method Investment
IncomeLossFromEquityMethodInvestment
1357 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
477647 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-69709 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-110069 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36979 usd
njmc Increase Decrease In Joint Venture Receivable
IncreaseDecreaseInJointVentureReceivable
-667 usd
njmc Increase Decrease In Joint Venture Receivable
IncreaseDecreaseInJointVentureReceivable
-372 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-64801 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-70402 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
248611 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-36703 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
19517 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
56303 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5209442 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1143346 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
583841 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
343356 usd
us-gaap Payments For Deposits On Real Estate Acquisitions
PaymentsForDepositsOnRealEstateAcquisitions
345907 usd
us-gaap Payments For Deposits On Real Estate Acquisitions
PaymentsForDepositsOnRealEstateAcquisitions
0 usd
njmc Proceeds From Sale Of Investments In Equity Securities
ProceedsFromSaleOfInvestmentsInEquitySecurities
0 usd
njmc Proceeds From Sale Of Investments In Equity Securities
ProceedsFromSaleOfInvestmentsInEquitySecurities
8500 usd
us-gaap Payments To Acquire Mining Assets
PaymentsToAcquireMiningAssets
960388 usd
us-gaap Payments To Acquire Mining Assets
PaymentsToAcquireMiningAssets
523785 usd
njmc Payment To Acquire Recalmation Bonds
PaymentToAcquireRecalmationBonds
-5000 usd
njmc Payment To Acquire Recalmation Bonds
PaymentToAcquireRecalmationBonds
0 usd
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
6322863 usd
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
0 usd
njmc Proceeds From Sale Of Investment In Equity Securities
ProceedsFromSaleOfInvestmentInEquitySecurities
5196 usd
njmc Proceeds From Sale Of Investment In Equity Securities
ProceedsFromSaleOfInvestmentInEquitySecurities
0 usd
njmc Equity Securities Gain Loss
EquitySecuritiesGainLoss
0 usd
njmc Equity Securities Gain Loss
EquitySecuritiesGainLoss
11100 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8212803 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-869741 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2160884 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
878503 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
990019 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
njmc Proceeds From Issuance Of Common Stock For Stock Options Exercised
ProceedsFromIssuanceOfCommonStockForStockOptionsExercised
150001 usd
njmc Proceeds From Issuance Of Common Stock For Stock Options Exercised
ProceedsFromIssuanceOfCommonStockForStockOptionsExercised
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
795530 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
502948 usd
njmc Principal Payments On Notes Payable Related Parties
PrincipalPaymentsOnNotesPayableRelatedParties
0 usd
njmc Principal Payments On Notes Payable Related Parties
PrincipalPaymentsOnNotesPayableRelatedParties
75183 usd
njmc Contributions From Non Controlling Interest
ContributionsFromNonControllingInterest
12245 usd
njmc Contributions From Non Controlling Interest
ContributionsFromNonControllingInterest
18010 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2517619 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
318382 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-485742 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
591987 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2286999 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1638031 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1801257 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2230018 usd
njmc Payments To Acquired Property Plant And Equipment
PaymentsToAcquiredPropertyPlantAndEquipment
30719 usd
njmc Payments To Acquired Property Plant And Equipment
PaymentsToAcquiredPropertyPlantAndEquipment
76110 usd
njmc Notes Payable For Equipment And Land Purchase
NotesPayableForEquipmentAndLandPurchase
559752 usd
njmc Notes Payable For Equipment And Land Purchase
NotesPayableForEquipmentAndLandPurchase
1110737 usd
njmc Notes Payable For Mineral Property Purchase
NotesPayableForMineralPropertyPurchase
650000 usd
njmc Notes Payable For Mineral Property Purchase
NotesPayableForMineralPropertyPurchase
0 usd
njmc Stock Options
StockOptions
<p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>13. Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There were no stock options granted during the six-months ended June 30, 2024 and 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Activity in the Company’s stock options is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Number of </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Options</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Weighted Average Exercise Prices</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">535,953</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.47</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(58,504</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.47</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">477,449</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.47</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(22,073</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(10,144</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.50</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance March 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">445,232</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.47</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:15px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(218,867</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.52</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding and exercisable at June 30, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">226,365</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.42</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In the three and six-month periods ending June 30, 2024, 197,438 and 214,154 options were exchanged for 86,481 and 92,386 shares in a cashless exercise by employees. The intrinsic value of these options was $854,761 and $919,990 for the three and six-month periods ending June 30, 2024. At June 30, 2024, outstanding stock options have a weighted average remaining term of approximately 0.68 years and have an intrinsic value of $1,005,415.</p>
CY2024Q2 njmc Share Based Compensation Arrangement By Share Based Payment Award Option Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriod
197438 shares
njmc Share Based Compensation Arrangement By Share Based Payment Award Option Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriod
214154 shares
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
6344725 usd
CY2023Q4 us-gaap Other Investments And Securities At Cost
OtherInvestmentsAndSecuritiesAtCost
5649 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
25073 shares

Files In Submission

Name View Source Status
0001654954-24-009573-index-headers.html Edgar Link pending
0001654954-24-009573-index.html Edgar Link pending
0001654954-24-009573.txt Edgar Link pending
0001654954-24-009573-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
njmc-20240630.xsd Edgar Link pending
njmc_10q.htm Edgar Link pending
njmc_ex311.htm Edgar Link pending
njmc_ex312.htm Edgar Link pending
njmc_ex321.htm Edgar Link pending
njmc_ex322.htm Edgar Link pending
njmc_ex95.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
njmc-20240630_cal.xml Edgar Link unprocessable
njmc-20240630_def.xml Edgar Link unprocessable
njmc-20240630_lab.xml Edgar Link unprocessable
njmc-20240630_pre.xml Edgar Link unprocessable
njmc_10q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable